APOPTOSIS OF HUMAN ANDROGEN-DEPENDENT PROSTATE CANCER LNCAP CELLS TREATED WITH ANDROGEN RECEPTOR ELEMENT DECOY OLIGONUCLEOTIDES

被引：0
|
作者：
Lifeng, Y. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Dept Urol, Shanghai, Peoples R China
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60650-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [31] Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor
    Xu Bin
    Sun Yinghao
    Tang Gusheng
    Xu Chuanliang
    Wang Linhui
    Zhang Yuxi
    Ji Jiatao
    CANCER LETTERS, 2009, 278 (02) : 220 - 229
  • [32] Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells
    Erzurumlu, Yalcin
    Dogan, Hatice Kubra
    Catakli, Deniz
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 20 (06) : 368 - 373
  • [33] Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
    Vindrieux, David
    Reveiller, Marie
    Chantepie, Jacqueline
    Yakoub, Sadok
    Deschildre, Catherine
    Ruffion, Alain
    Devonec, Marian
    Benahmed, Mohamed
    Grataroli, Renee
    CANCER CELL INTERNATIONAL, 2011, 11
  • [34] Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
    David Vindrieux
    Marie Réveiller
    Jacqueline Chantepie
    Sadok Yakoub
    Catherine Deschildre
    Alain Ruffion
    Marian Devonec
    Mohamed Benahmed
    Renée Grataroli
    Cancer Cell International, 11
  • [35] Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells
    Kumagai, T
    Tomari, K
    Shimizu, T
    Takeda, K
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 285 - 291
  • [36] 1 alpha 25-dihydroxyvitamin D-3 actions in LNCaP human prostate cancer cells are androgen-dependent
    Zhao, XY
    Ly, LH
    Peehl, DM
    Feldman, D
    ENDOCRINOLOGY, 1997, 138 (08) : 3290 - 3298
  • [37] Cell proliferation control by testosterone and letrozole in lncap androgen-dependent prostate cancer cells: Involvement of the glyoxalase system
    Mearini, E.
    Talesa, V. N. Z.
    Cottini, E.
    Fioretti, F.
    Buono, C. Z.
    Antognelli, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 45 - 45
  • [38] Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence
    Zheng, Xi
    Cui, Xiao-Xing
    Gao, Zhi
    Zhao, Yang
    Lin, Yong
    Shih, Weichung Joe
    Huang, Mou-Tuan
    Liu, Yue
    Rabson, Arnold
    Reddy, Bandaru
    Yang, Chung S.
    Conney, Allan H.
    CANCER PREVENTION RESEARCH, 2010, 3 (01) : 114 - 124
  • [39] Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells
    Inoue, Takahiro
    Yoshida, Toru
    Shimizu, Yosuke
    Kobayashi, Takashi
    Yamasaki, Toshinari
    Toda, Yoshinobu
    Segawa, Takehiko
    Kamoto, Toshiyuki
    Nakamura, Eijiro
    Ogawa, Osamu
    MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) : 3053 - 3069
  • [40] Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells
    Wang, QB
    Udayakumar, TS
    Vasaitis, TS
    Brodie, AM
    Fondell, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17319 - 17328
12345